These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 16173330)

  • 21. Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial.
    Martin RM; Donovan JL; Turner EL; Metcalfe C; Young GJ; Walsh EI; Lane JA; Noble S; Oliver SE; Evans S; Sterne JAC; Holding P; Ben-Shlomo Y; Brindle P; Williams NJ; Hill EM; Ng SY; Toole J; Tazewell MK; Hughes LJ; Davies CF; Thorn JC; Down E; Davey Smith G; Neal DE; Hamdy FC;
    JAMA; 2018 Mar; 319(9):883-895. PubMed ID: 29509864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Supporting informed decision making for prostate specific antigen (PSA) testing on the web: an online randomized controlled trial.
    Evans R; Joseph-Williams N; Edwards A; Newcombe RG; Wright P; Kinnersley P; Griffiths J; Jones M; Williams J; Grol R; Elwyn G
    J Med Internet Res; 2010 Aug; 12(3):e27. PubMed ID: 20693148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial.
    Gattellari M; Ward JE
    J Med Screen; 2003; 10(1):27-39. PubMed ID: 12790313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for prostate cancer.
    Ilic D; Neuberger MM; Djulbegovic M; Dahm P
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recruitment of African Americans into prostate cancer screening.
    Weinrich SP; Boyd MD; Bradford D; Mossa MS; Weinrich M
    Cancer Pract; 1998; 6(1):23-30. PubMed ID: 9460323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
    O'Dell KJ; Volk RJ; Cass AR; Spann SJ
    J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate-specific antigen test use and digital rectal examinations among African-American men, 2002-2006.
    Ross LE; Meade SA; Powe BD; Howard DL
    J Natl Black Nurses Assoc; 2009 Jul; 20(1):52-8. PubMed ID: 19691184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
    Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
    Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of prostate cancer among men aged 40+ living in Osman Gazi health care district.
    Çeber E; Şimşir A; Umar DÇ; Karababa AO; Günaydın G; Çal Ç; Özentürk G
    Asian Pac J Cancer Prev; 2010; 11(2):473-8. PubMed ID: 20843136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns in prostate-specific antigen test use and digital rectal examinations in the Behavioral Risk Factor Surveillance System, 2002-2006.
    Ross LE; Taylor YJ; Richardson LC; Howard DL
    J Natl Med Assoc; 2009 Apr; 101(4):316-24. PubMed ID: 19397221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey.
    Ross LE; Berkowitz Z; Ekwueme DU
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):636-44. PubMed ID: 18349281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.
    van Vugt HA; Roobol MJ; Venderbos LD; Joosten-van Zwanenburg E; Essink-Bot ML; Steyerberg EW; Bangma CH; Korfage IJ
    Eur J Cancer; 2010 Feb; 46(3):669-77. PubMed ID: 20022239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-literacy interventions to promote discussion of prostate cancer: a randomized controlled trial.
    Kripalani S; Sharma J; Justice E; Justice J; Spiker C; Laufman LE; Price M; Weinberg AD; Jacobson TA
    Am J Prev Med; 2007 Aug; 33(2):83-90. PubMed ID: 17673094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of informed consent on patient interest in prostate-specific antigen screening.
    Wolf AM; Nasser JF; Wolf AM; Schorling JB
    Arch Intern Med; 1996 Jun; 156(12):1333-6. PubMed ID: 8651843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparing African American Men to Make Informed Prostate Cancer Screening Decisions: Development and Pilot Testing of an Interactive Online Decision Aid.
    Allen JD; Reich A; Cuevas AG; Ladin K
    JMIR Mhealth Uhealth; 2020 May; 8(5):e15502. PubMed ID: 32369032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
    Tasian GE; Cooperberg MR; Cowan JE; Keyashian K; Greene KL; Daniels NA; Carroll PR; Chan JM
    Urol Oncol; 2012; 30(2):155-60. PubMed ID: 20800514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of healthcare barriers with prostate-specific antigen screening among African-American and Afro-Caribbean men.
    Lee DJ; Consedine NS; Gonzalez JR; Spencer BA
    Urology; 2012 Sep; 80(3):556-63. PubMed ID: 22789295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.
    Thomas R; Glasziou P; Rychetnik L; Mackenzie G; Gardiner R; Doust J
    BMJ Open; 2014 Dec; 4(12):e005691. PubMed ID: 25539779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. National evidence on the use of shared decision making in prostate-specific antigen screening.
    Han PK; Kobrin S; Breen N; Joseph DA; Li J; Frosch DL; Klabunde CN
    Ann Fam Med; 2013; 11(4):306-14. PubMed ID: 23835816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.